← 返回

可注射水凝胶微球整合的训练场激发肿瘤浸润 T 淋巴细胞潜能

英文原题:An injectable hydrogel microsphere-integrated training court to inspire tumor-infiltrating T lymphocyte potential.

查看英文原题

An injectable hydrogel microsphere-integrated training court to inspire tumor-infiltrating T lymphocyte potential.

PubMed 2024/01/25(内容时间) Biomaterials Q1 · IF 13.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

尽管肿瘤浸润性T淋巴细胞(TIL-Ts)在实体瘤免疫治疗中发挥着关键作用,但其临床应用因免疫抑制性微环境而受到限制。在此,我们开发了一种可注射的水凝胶微球集成训练场(MS-ITC),通过接枝抗CD3和抗CD28抗体以及包载IL-7和IL-15的牛血清白蛋白纳米颗粒,来激发TIL-Ts的功能并扩增TIL-Ts。MS-ITC提供了TIL-Ts活化所需的T细胞受体和共刺激信号,以及用于TIL-Ts扩增的IL-7/IL-15信号。随后,将MS-ITC局部注射到小鼠骨肉瘤肿瘤组织中。MS-ITC对原发性骨肉瘤生长的抑制超过95%,同时肿瘤组织中的TIL-Ts被激活并扩增,CD8+ T细胞和记忆T细胞显著增加,从而增强了抗肿瘤效果。总之,这项工作提供了一种可注射的水凝胶微球集成训练平台,能够激发TIL-Ts在一系列实体瘤免疫治疗中的潜力。

展开英文摘要原文

Although tumor-infiltrating T lymphocytes (TIL-Ts) play a crucial role in solid tumor immunotherapy, their clinical application has been limited because of the immunosuppressive microenvironment.

Herein, we developed an injectable hydrogel microsphere-integrated training court (MS-ITC) to inspire the function of TIL-Ts and amplify TIL-Ts, through grafting with anti-CD3 and anti-CD28 antibodies and bovine serum albumin nanoparticles encapsulated with IL-7 and IL-15. MS-ITC provided the T-cell receptor and co-stimulatory signals required for TIL-Ts activation and IL-7/IL-15 signals for TIL-Ts expansion.

Afterward, the MS-ITC was injected locally into the osteosarcoma tumor tissue in mice. MS-ITC suppressed the growth of primary osteosarcoma by more than 95 %, accompanied with primed and expanded TIL-Ts in the tumor tissues, compromising significantly increased CD8 + T and memory T cells, thereby enhancing the anti-tumor effect.

Together, this work provides an injectable hydrogel microsphere-integrated training platform capable of inspiring TIL-Ts potential for a range of solid tumor immunotherapy.

论文信息

作者
He J、Niu J、Wang L、Zhang W、He X、Zhang X、Hu W、Tang Y
第一作者单位
Department of Orthopedics, National Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Suzhou Medical College of Soochow University, 899 Pinghai Road, Suzhou, Jiangsu, 215031, PR China.China
通讯作者单位
Department of Orthopedics, National Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Suzhou Medical College of Soochow University, 899 Pinghai Road, Suzhou, Jiangsu, 215031, PR China. Electronic address: shiqin@suda.edu.cn.China
文献类型
美国政府(非公共卫生署)资助研究
期刊
Biomaterials2024 Apr
原文标识
PubMed 38306733 · DOI 10.1016/j.biomaterials.2024.122475